dabigatran

Pradaxa, also known by its generic name dabigatran, is approved outside the U.S. to prevent blood clots in patients undergoing knee - or hip-replacement surgery.

Drug to Prevent Stroke Is Approved Jennifer Corbett Dooren 2010

Pradaxa, also known by its generic name dabigatran, is approved outside the U.S. to prevent blood clots in patients undergoing knee or hip replacement surgery.

Blood Drug Gets Nod 2010

In addition to Boehringer Ingelheim's dabigatran, which is on the market in Europe for stroke prevention after hip and knee surgery, at least three other compounds are in or moving into late stages of development as alternatives to warfarin.

New Blood Thinner Matches Warfarin 2009

In an 18,113-patient trial, a high dose of the drug, called dabigatran, reduced the rate of stroke by 34% compared to warfarin, with a comparable rate of major bleeding episodes.

New Blood Thinner Matches Warfarin 2009

Now the FDA has approved the first alternative anti-clotting drug, called dabigatran - brand name

NPR Topics: News 2010

Now the FDA has approved the first alternative anti-clotting drug, called dabigatran - brand name

NPR Topics: News 2010

Now the FDA has approved the first alternative anti-clotting drug, called dabigatran - brand name

NPR Topics: News 2010

Now the FDA has approved the first alternative anti-clotting drug, called dabigatran - brand name

NPR Topics: News 2010

However, this study shows that an oral drug called dabigatran etexilate, which does not have these disadvantages, is as safe and effective as warfarin for combating VTE.

unknown title 2009

Pradaxa, also known as dabigatran etexilate, was shown in the study not to cause liver damage, a side effect that in 2006 thwarted an early attempt by AstraZeneca to bring a new oral blood thinner to market.

FinanzNachrichten.de: Aktuelle Nachrichten 2009